Ozempic vs Wegovy: What’s the Difference and Which Should You Choose?

Ozempic and Wegovy: The Same Drug, Different Purposes

Ozempic and Wegovy are both brand names for the same active ingredient: semaglutide. The key difference lies in their approved uses and doses. Ozempic (0.5 mg, 1 mg, and 2 mg weekly doses) is licensed in the UK for the management of type 2 diabetes. Wegovy (2.4 mg weekly) is specifically approved for chronic weight management in adults with obesity or overweight with weight-related health conditions.

Understanding this distinction is essential for anyone considering semaglutide treatment, as it affects prescribing criteria, NHS availability, and insurance coverage.

The Key Differences Explained

Dose

The most significant clinical difference between Ozempic and Wegovy is the maximum dose. Wegovy is titrated up to 2.4 mg per week, while Ozempic’s maximum approved dose is 2 mg per week. The higher dose in Wegovy is associated with greater weight loss — an important factor for those whose primary goal is substantial weight reduction.

Approved Indication

Ozempic is prescribed for type 2 diabetes management, with weight loss being a beneficial side effect. Wegovy is specifically designed and licensed for weight management in people who do not necessarily have diabetes.

Prescribing Criteria

Because of their different indications, the prescribing criteria differ. For Ozempic, patients typically need a diagnosis of type 2 diabetes. For Wegovy, eligibility is based on BMI: 30+ kg/m² (obese) or 27+ kg/m² with a weight-related health condition.

Which Produces More Weight Loss?

Head-to-head data is limited, but the higher dose in Wegovy (2.4 mg vs 2 mg) appears to produce modestly greater weight loss. In the STEP 1 trial using Wegovy, participants lost an average of 14.9% of body weight. In contrast, studies using Ozempic at 1–2 mg doses showed average weight loss of 4–6% in diabetic populations, though these populations tend to lose less weight than non-diabetic patients.

For weight loss as a primary goal, Wegovy is generally the preferred option when available.

Availability and Cost in the UK

Both Ozempic and Wegovy have faced significant supply challenges due to global demand. Wegovy is available in the UK through specialist weight management services and private clinics. Ozempic is more widely available but should only be prescribed off-label for weight loss by appropriately qualified clinicians who have assessed the patient’s full clinical picture.

At Metabolic Slim Clinic, we work with a regulated supply chain and ensure that medications are prescribed safely and appropriately. We do not contribute to shortages that affect patients with type 2 diabetes.

Side Effects: Are They Different?

Because Ozempic and Wegovy contain the same molecule (semaglutide), their side effect profiles are essentially identical. The most common side effects include nausea, vomiting, diarrhoea, constipation, and reduced appetite. At the higher Wegovy dose, gastrointestinal side effects may be slightly more pronounced, which is why the gradual dose titration schedule is important.

Can I Get Semaglutide Through Metabolic Slim Clinic?

Yes. Metabolic Slim Clinic’s specialist doctors can prescribe semaglutide as part of a medically supervised weight loss programme. We will assess your eligibility, discuss the most appropriate dose and formulation for your circumstances, and provide ongoing clinical oversight throughout your treatment.

If you are wondering whether Ozempic or Wegovy is the right choice for you, the best first step is a conversation with one of our doctors. Book your consultation today.